Another article that mentions HEB.
Ebola lobbying hits Washington
By Kimberly Railey
krailey@dallasnews.com
10:55 am on October 30, 2014 | Permalink
WASHINGTON — Ebola lobbying is going viral in Washington.
Over July through September, more than 15 groups cited the disease in lobbying reports filed with the Secretary of the Senate’s Office of Public Records. The organizations include drugmakers, hospitals and health professional associations, according to the Center for Responsive Politics, which noted the lobbying trend.
Cerus Corporation, which is seeking compassionate use approval of its anti-viral blood treatment technology, has spent $20,000, the reports indicate. Zimek Technologies, which has touted its disinfecting system for hospital rooms, also shelled out $20,000.
Another company, Hemispherx BioPharma, brought on the firm Squire Patton Boggs to “to bring our experimental drug Ampligen and FDA approved drug Alferon online as potential therapeutics for Ebola,” according to a statement provided to Politico.
Last month, Congress approved $88 billion for Ebola drug research as part of a short-term spending bill. There aren’t any drugs or vaccines approved to treat the disease in the U.S., but several experimental drugs have been used.
Another company, Sanford Health, has been lobbying on “issues related to [the] Ebola outbreak, including education, research and funding needed for treatment,” according to the filings.
Other organizations that listed Ebola in the reports include Sarepta Therapeutics, which is pushing for fast-track approval of its experimental Ebola treatment, and ONE Action, U2 singer Bono’s advocacy group.
